This review discusses treatment trends and management approaches for rising metabolic-dysfunction-associated steatotic liver disease cases.
The incidence of Metabolic-dysfunction-associated steatotic liver disease (MASLD) is on the rise worldwide. The purpose of this paper is to review the current and emerging trends in the management and treatment of the condition.
No takes yet. Share an insight, caveat, or question.
Pranav Patel (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: